2Valgimigli M,Agustoni P,Serrovs PW.Acute coronary syndromes:an emphasis shift from treatment to prevention;and the enduring challenge of vulnerable plaque detection in the cardiac eatheterization laboratory.J Cardiovasc Med(Hagerstown),2007,8(4):221. 被引量：1
3Erkkila AT,Narvanen O,Lehta S,et al.Autoantibodies against oxidized low density lipoprotein and cardiolipin in patients with coronary heart disease.Arterioscler Thromb Vasc Biol,2000,20(1):204. 被引量：1
4Moreno PR,Ledder RA,Purushothaman KR,et al.Detection of lipid pool,thin fibronscap,and inflammatory cells in human aortic atherosclerotie plaques by near infrared spectroscopy.Circulation,2002,105(8):923. 被引量：1
5Rauch U,Osende JI,Chesebro JH,et al.Statins and cardiovascular disease:the multiple effects of lipid-lowering therapy by statins.Atheroscleresis,2000,153(1):181. 被引量：1
7Westhuyzen J,Healy H.Review:bioligy and relevance of C-reactive protein in cardiovascular and renal disease.Ann Clin Lab Sci,2000,30(2):133. 被引量：1
8Heeachen C,Dinuneler S,Harem CW,et al.Preguance-associated plasma petein-A levels in patients with acute coronary syndromes:comparison with markers of systemic inflammation,platelet activation,and myocardial necrosis.J Am Coil Cardiol,2005,45(2):229. 被引量：1
9Ehara S,Ueda M,Naruko T,et al.Elevated levels of oxidizwd low density lipoprotein show a positive correlation with the severity of acute coronary syndromes.Circulation,2001,103(15):1955. 被引量：1
10Shah VK,Shalia KK,Mashru MR,et al.Role of matrix etalloprotsinases in coronary artery disease.Indisn Heart J,2009,61(1):44. 被引量：1
